Abstract: Methods of screening and designing compounds as inhibitors of glutamine synthetase, including adenylylated glutamine synthetase, are provided herein. Compounds and compositions useful for the treatment, prevention, and/or amelioration of bacterial infections, including Mycobacterium tuberculosis, are also provided.
| # | Name | Date |
|---|---|---|
| 1 | 2202-MUMNP-2008- AFR.pdf | 2022-04-26 |
| 1 | 2202-mumnp-2008-form 3(15-10-2008).pdf | 2008-10-15 |
| 2 | 2202-MUMNP-2008- OTHER DOCUMENT.pdf | 2022-04-26 |
| 2 | 2202-mumnp-2008-form 2(15-10-2008).pdf | 2008-10-15 |
| 3 | 2202-mumnp-2008-description(complete)-(15-10-2008).pdf | 2008-10-15 |
| 3 | 2202-MUMNP-2008- PCT DOCUMENT.pdf | 2022-04-26 |
| 4 | 2202-MUMNP-2008_EXAMREPORT.pdf | 2018-08-09 |
| 4 | 2202-MUMNP-2008- PUBLICATION REPORT.pdf | 2022-04-26 |
| 5 | 2202-MUMNP-2008-PUBLICATION REPORT(4-12-2009).pdf | 2018-08-09 |
| 5 | 2202-mumnp-2008-abstract.pdf | 2018-08-09 |
| 6 | 2202-mumnp-2008-power of attorney.pdf | 2018-08-09 |
| 6 | 2202-MUMNP-2008-ANNEXURE TO FORM 3(2-2-2009).pdf | 2018-08-09 |
| 7 | 2202-mumnp-2008-form 5.pdf | 2018-08-09 |
| 7 | 2202-mumnp-2008-claims.pdf | 2018-08-09 |
| 8 | 2202-mumnp-2008-form 3.pdf | 2018-08-09 |
| 8 | 2202-MUMNP-2008-CORRESPONDENCE(2-2-2009).pdf | 2018-08-09 |
| 9 | 2202-MUMNP-2008-CORRESPONDENCE(4-12-2009).pdf | 2018-08-09 |
| 9 | 2202-mumnp-2008-form 2.pdf | 2018-08-09 |
| 10 | 2202-MUMNP-2008-CORRESPONDENCE(IPO)-(30-1-2013).pdf | 2018-08-09 |
| 10 | 2202-mumnp-2008-form 2(title page).pdf | 2018-08-09 |
| 11 | 2202-mumnp-2008-correspondence.pdf | 2018-08-09 |
| 11 | 2202-MUMNP-2008-FORM 18(4-12-2009).pdf | 2018-08-09 |
| 12 | 2202-mumnp-2008-description(complete).pdf | 2018-08-09 |
| 12 | 2202-mumnp-2008-form 1.pdf | 2018-08-09 |
| 13 | 2202-mumnp-2008-drawing.pdf | 2018-08-09 |
| 14 | 2202-mumnp-2008-description(complete).pdf | 2018-08-09 |
| 14 | 2202-mumnp-2008-form 1.pdf | 2018-08-09 |
| 15 | 2202-mumnp-2008-correspondence.pdf | 2018-08-09 |
| 15 | 2202-MUMNP-2008-FORM 18(4-12-2009).pdf | 2018-08-09 |
| 16 | 2202-MUMNP-2008-CORRESPONDENCE(IPO)-(30-1-2013).pdf | 2018-08-09 |
| 16 | 2202-mumnp-2008-form 2(title page).pdf | 2018-08-09 |
| 17 | 2202-mumnp-2008-form 2.pdf | 2018-08-09 |
| 17 | 2202-MUMNP-2008-CORRESPONDENCE(4-12-2009).pdf | 2018-08-09 |
| 18 | 2202-MUMNP-2008-CORRESPONDENCE(2-2-2009).pdf | 2018-08-09 |
| 18 | 2202-mumnp-2008-form 3.pdf | 2018-08-09 |
| 19 | 2202-mumnp-2008-form 5.pdf | 2018-08-09 |
| 19 | 2202-mumnp-2008-claims.pdf | 2018-08-09 |
| 20 | 2202-mumnp-2008-power of attorney.pdf | 2018-08-09 |
| 20 | 2202-MUMNP-2008-ANNEXURE TO FORM 3(2-2-2009).pdf | 2018-08-09 |
| 21 | 2202-MUMNP-2008-PUBLICATION REPORT(4-12-2009).pdf | 2018-08-09 |
| 21 | 2202-mumnp-2008-abstract.pdf | 2018-08-09 |
| 22 | 2202-MUMNP-2008_EXAMREPORT.pdf | 2018-08-09 |
| 22 | 2202-MUMNP-2008- PUBLICATION REPORT.pdf | 2022-04-26 |
| 23 | 2202-mumnp-2008-description(complete)-(15-10-2008).pdf | 2008-10-15 |
| 23 | 2202-MUMNP-2008- PCT DOCUMENT.pdf | 2022-04-26 |
| 24 | 2202-mumnp-2008-form 2(15-10-2008).pdf | 2008-10-15 |
| 24 | 2202-MUMNP-2008- OTHER DOCUMENT.pdf | 2022-04-26 |
| 25 | 2202-MUMNP-2008- AFR.pdf | 2022-04-26 |
| 25 | 2202-mumnp-2008-form 3(15-10-2008).pdf | 2008-10-15 |